Takeda New Frontier Science (NFS) aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients' lives.

Takeda New Frontier Science (NFS) aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients' lives.

Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), while Ilan Zipkin and Gordon Wong join.

Johnson & Johnson is setting up four innovation centres in California and Boston in the US, in the UK and in Shanghai, China.

France-based pharmaceutical company Ipsen is joined backing the US-based diabetes and obesity treatment company by venture firms MPM Capital, New Enterprise Associates, and Third Rock Ventures.

Qualcomm's corporate venturing unit backs the US-based maker of mobile applications for heart monitoring, for a second time.

US-based healthcare companies Merck and Cleveland Clinic outline their strategies in these edited highlights from Global Corporate Venturing's symposium last month in London.

Johnson & Johnson's unbroken history of taking minority equity stakes in third-party entrepreneurs marks it as one of the oldest and most consistent investors in corporate venturing, writes James Mawson

Merck Serono is finding its unconventional decision to opt for a strategic approach to the life sciences is sector yielding success.